Mr Ali Alhamdani

FRCS, MD, MB ChB

Consultant Bariatric Surgeon

Bariatric surgery

Management of obese patients.

Mr Alhamdani provides laparoscopic surgery for digestive disorders. He is experienced in weight loss surgery. 
 
Mr Alhamdani completed his medical degree at the College of Medicine, University of Baghdad in 1996. Moving to the UK in 1998, and after completing his basic and higher surgical training, he was awarded MD in Molecular Genetics by Swansea University in 2006. 
 
Mr Alhamdani has been a Fellow of the Royal College of Surgeons (FRCS) and a JAG certified endoscopist since 2010. After his obesity surgery fellowship program in at the Sunderland Royal Hospital he moved to London as a Consultant Obesity Surgeon.

English, Arabic

Yes

Mon: Tue: Wed: Thurs: Fri: Sat:

020 7460 5700

1996

Fellow of the Royal College of Surgeons of Edinburgh, Member of British Society of Obesity and Metabol Surgery (BOMSS), Member of the International Federation For the Surgery of Obesity and Metabolic Disorders.

Whittington

Optimizing the surgical care of obese patients.

Laparoscopic adjustable gastric banding: a 10-year single centre experience of 575 cases with weight loss following surgery. 
 
Curcumin abrogates bile-induced NF-?B activity and DNA damage in vitro and suppresses NF-?B activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus. 
 
In vitro and ex vivo models of extended reflux exposure demonstrate that weakly acidic mixed reflux heightens NF-kB-mediated gene expression. 
Primary closure of choledochotomy after emergency laparoscopic common bile duct exploration. 
 
The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.